RM
Highly rated in
21
conditions
Highly rated in
21
conditions
Check Dr. Rafael R. Manon's experience treating your condition:
About Dr. Rafael R. Manon

Rafael Manon is a Radiation Oncologist in Orlando, Florida. Manon has been practicing medicine for over 22 years and is highly rated in 21 conditions, according to our data. His top areas of expertise are Laryngeal Cancer, Salivary Gland Tumors, Throat Cancer, and Medullary Thyroid Carcinoma. He is licensed to treat patients in Florida. Manon is currently accepting new patients.

His clinical research consists of co-authoring 15 peer reviewed articles and participating in 3 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Rafael R. Manon it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Rafael R. Manon accepts the following insurance:

  •  Ambetter
  •  Molina Healthcare
  •  Cigna
  •  Sunshine Health
  •  AvMed

Call to see if your plan is accepted.
Locations
1400 S Orange Ave, Orlando, FL 32806
Other Locations
9900 W Colonial Dr, Ocoee, FL 34761
Background & Education
Graduate Institution
University Of Florida College Of Medicine, 2000
Specialties
Radiation Oncology
Licenses
Radiology in FL
Hospital Affiliations
Orlando Health Orlando Regional Medical Center
Orlando Health South Lake Hospital
Orlando Health South Seminole Hospital
Orlando Health - Health Central Hospital
Languages Spoken
English
Spanish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
View 2 Less Clinical Trial -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors